Concentrix Corp — Form 8-K
Filed September 29, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 68/100
What the filing says
Concentrix recorded a $1.05B non-cash goodwill impairment charge in Q3 2026 (ended Aug 31) due to depressed stock price and market capitalization, reducing reported operating income to -$910M vs. +$147M prior year. Excluding the impairment, non-GAAP operating income grew 1.3% to $309M and adjusted free cash flow reached record $218M. The board raised the quarterly dividend from $0.36 to $0.37 per share (effective Nov 3, 2026). Full-year guidance shows constant-currency revenue decline of 0.3%-0.8% and non-GAAP EPS of $10.97–$11.09 on ~61.1M diluted shares.
Why this rating
Impairment signals market undervalues the company (36% of $2.9B market cap), but operating fundamentals stable. Dividend increase and strong FCF mitigate concern. Material event for equity holders but operational business resilient.
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.